Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Alto Neuroscience, Inc. (ANRO) Gross Margin data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-61.43M |
|
-- |
|
-- |
|
$68.61M |
|
$-68.61M |
|
$7.18M |
|
$-61.43M |
|
$-61.43M |
|
$-61.43M |
|
$-61.43M |
|
$-61.43M |
|
$-61.43M |
|
$-68.61M |
|
$-68.11M |
|
24.60M |
|
24.60M |
|
$-2.50 |
|
$-2.50 |
|
| Balance Sheet Financials | |
$169.34M |
|
$2.67M |
|
$8.21M |
|
$177.54M |
|
$10.01M |
|
$11.56M |
|
$16.07M |
|
$26.08M |
|
$151.46M |
|
$151.46M |
|
$151.46M |
|
26.99M |
|
| Cash Flow Statement Financials | |
$-47.42M |
|
$-2.08M |
|
$135.69M |
|
$82.55M |
|
$168.73M |
|
$86.18M |
|
$7.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.92 |
|
-- |
|
-- |
|
0.07 |
|
0.08 |
|
|
Gross Margin |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.56% |
|
-40.56% |
|
-34.60% |
|
-37.68% |
|
$5.61 |
|
$-2.01 |
|
$-1.93 |
|